Cogent Biosciences
COGT
COGT
134 hedge funds and large institutions have $1.13B invested in Cogent Biosciences in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding
Funds holding: 112 → 134 (+22)
5.37% more ownership
Funds ownership: 110.32% → 115.69% (+5.4%)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
134
Holding in Top 10
7
Calls
$1.42M
Puts
$308K
Top Buyers
| 1 | +$59.9M | |
| 2 | +$40.5M | |
| 3 | +$20.3M | |
| 4 |
BlackRock
New York
|
+$19.4M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$18.8M |
Top Sellers
| 1 | -$43.4M | |
| 2 | -$33.3M | |
| 3 | -$14.7M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$11.3M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$9.75M |